RCM
RMD icon

Reynolds Capital Management’s ResMed RMD Stock Holding History

Reynolds Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,900
Closed -$280K – 251
2015
Q1 		$280K Buy
+3,900
New +$253K 0.24% 155

Other funds holding RMD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Reynolds Capital Management's RMD Position: Q2 2015 in Review

Reynolds Capital Management sold out of ResMed (RMD) in Q2 2015, closing a stake of 3,900 shares — an estimated $280K sold.

Reynolds Capital Management first reported a position in RMD in Q1 2015 and held it in 1 quarter. The position peaked at $280K in Q1 2015. 312 funds tracked by Wall St. Rank hold RMD as of Q2 2015.

  • Reynolds Capital Management reported no remaining ResMed position as of Q2 2015 after selling out during the quarter.
  • Reynolds Capital Management sold 3,900 ResMed shares in Q2 2015, an estimated $280K.
  • Reynolds Capital Management first reported a position in ResMed in Q1 2015 and held it in 1 quarter.
  • Reynolds Capital Management's ResMed position peaked at $280K in Q1 2015.
  • 312 funds tracked by Wall St. Rank held ResMed as of Q2 2015.

Based on Reynolds Capital Management's 13F filing for Q2 2015, filed 12 Aug 2015.